[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation]

MeSH terms

• Anti-Bacterial Agents / therapeutic use
• Anti-Infective Agents / therapeutic use*
• Antifungal Agents / therapeutic use
• Antiviral Agents / therapeutic use
• Bacterial Infections / diagnosis
• Bacterial Infections / drug therapy
• Bacterial Infections / epidemiology*
• Fever / etiology
• Hematopoietic Stem Cell Transplantation / adverse effects*
• Humans
• Leukocyte Count
• Middle Aged
• Mycoses / diagnosis
• Mycoses / drug therapy
• Mycoses / epidemiology*
• Neutropenia / complications
• Neutrophils
• Pneumonia, Pneumocystis / diagnosis
• Pneumonia, Pneumocystis / drug therapy
• Postoperative Complications* / drug therapy
• Respiratory Tract Infections / diagnosis
• Respiratory Tract Infections / drug therapy
• Retrospective Studies
• Risk Factors
• Time Factors
• Toxoplasmosis / diagnosis
• Toxoplasmosis / therapy
• Transplantation, Homologous
• Virus Diseases / diagnosis
• Virus Diseases / drug therapy
• Virus Diseases / epidemiology*